Bartram Richard
Insider CIK 1723729 · ESPR Chief Financial Officer · MBX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MBX MBX Biosciences, Inc. | A Award deriv | 2026-02-02 | 2026-02-03 | 70,000 | — | $0 | 70,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award | 2026-02-02 | 2026-02-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 95,000 | — | $0 | 95,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2024-09-12 | 2024-09-13 | 42,578 | — | $0 | 42,578 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2022-03-14 | 2022-03-16 | 37,000 | — | $0 | 82,751 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2021-10-29 | 2021-11-01 | 18,700 | — | $0 | 43,852 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2021-06-28 | 2021-06-30 | 26,400 | — | $0 | 26,400 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2021-06-28 | 2021-06-30 | 37,500 | — | $0 | 37,500 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2021-01-28 | 2021-01-29 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2021-01-28 | 2021-01-29 | 5,000 | — | $0 | 23,617 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2020-01-02 | 2020-01-03 | 33,900 | — | $0 | 33,900 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2020-01-02 | 2020-01-03 | 7,525 | — | $0 | 18,673 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2019-04-03 | 2019-04-05 | 6,500 | $42.71 | $277.6K | 12,592 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2019-04-03 | 2019-04-05 | 1,500 | $43.62 | $65.4K | 11,092 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2018-11-28 | 2018-11-30 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2018-01-02 | 2018-01-03 | 38,500 | — | $0 | 38,500 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise deriv | 2018-01-02 | 2018-01-03 | 17,892 | — | $0 | 0 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | M Exercise | 2018-01-02 | 2018-01-03 | 17,892 | $3.70 | $66.2K | 19,092 | SEC↗ |